IE00B4BNMY34 - Common Stock
Based on the average brokerage recommendation (ABR), Accenture (ACN) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Accenture (ACN) concluded the recent trading session at $352.79, signifying a -0.22% move from its prior day's close.
Recently, Zacks.com users have been paying close attention to Accenture (ACN). This makes it worthwhile to examine what the stock has in store.
Chief among complaints are needing to book exact dates for another person and lacking required details to book on behalf of another, according to Accenture.
The market appreciates certainty; it got a clear read on the next U.S. presidential administration and the near-term interest rate outlook. We break it all down, and give you a little reset from all the big-picture talk.
The advertising agency that sells lamb on Australia Day will now sell the government’s Future Made in Australia package.
The diversity initiative follows a string of recent high-profile instances of harassment and inappropriate behaviour plaguing the local sector.
Investors need to pay close attention to Accenture (ACN) stock based on the movements in the options market lately.
The value of Commonwealth work outsourced to Accenture, Deloitte, EY, KPMG and PWC is down to $1.5 billion since Labor took power in mid-2022.
Accenture (ACN) concluded the recent trading session at $344.82, signifying a -0.5% move from its prior day's close.
The average brokerage recommendation (ABR) for Accenture (ACN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
The latest trading day saw Accenture (ACN) settling at $370.63, representing a -0.31% change from its previous close.